Clinical Trial Update: Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance

View source ↗

Summary

A recruiting clinical trial evaluating the combined use of Bacteroides fragilis and branched-chain amino acids on HBsAg clearance in patients with chronic hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Bacteroides fragilis (Bacteroides fragilis)
• branched-chain amino acids (branched-chain amino acids)

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Chronic Hepatitis B | Status: RECRUITING